Key facts
- It has raised $85.0M.
- Notable investors include OrbiMed, EMZ Partners, Acceleration International, DoubleMint Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for vVardis
- ·The full record, as it builds
Funding rounds
No funding rounds for vVardis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About vVardis
Manufacturer of dental care products designed to enhance overall health through improved oral health. The company's products utilize biomimetic peptide technology that can arrest and reverse early caries via in-depth remineralization and regeneration of enamel, providing clients of all age groups with protection from tooth decay, erosion, and sensitivity in a non-invasive manner.
- Sector
- Healthcare
- HQ
- Zug, Switzerland
- Founded
- 2003
- Employees
- 144
- Website
- vvardis.com/
- Ownership
- Privately Held (backing)
vVardis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in vVardis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on vVardis in its N-PORT filings yet. We sweep new filings monthly.